Our Published Reviews and Protocols

Cochrane Gut was formed in June 2020 by the merger of Cochrane Upper Gastrointestinal and Pancreatic Diseases and Cochrane IBD.

The reviews and protocols previously published by these two groups, as well as all reviews overseen by Cochrane Gut can be viewed in the Cochrane Library by using the 'Browse by Review Group' function and selecting 'Gut'.

Our Reviews

Full list:

By subtopic:

OESOPHAGUS (64)
Barrett's Oesophagus (1)
Diagnosis (0)
Prevention (0)
Treatment (1)
Endoscopic (0)
Pharmacology (0)
Surgery (1)
Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus
Cancer (31)
Diagnosis (0)
Palliation (4)
Percutaneous endoscopic gastrostomy versus percutaneous radiological gastrostomy for swallowing disturbances
Interventions for dysphagia in oesophageal cancer
Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer
Percutaneous radiological gastrostomies versus nasogastric tube feeding for people with swallowing disturbances (protocol stage)
Prevention (1)
Screening (1)
Screening for oesophageal cancer
Surgery (0)
Treatment (26)
Chemotherapy (7)
Preoperative chemotherapy for resectable thoracic esophageal cancer
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Non-surgical versus surgical treatment for oesophageal cancer
Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer
Preoperative chemoradiotherapy versus chemotherapy for adenocarcinoma of the esophagus and esophagogastric junction (AEG): systematic review with individual participant data (IPD) network meta-analysis (NMA) (protocol stage)
Preoperative radiotherapy chemotherapy and surgery versus surgery alone for esophageal cancer (protocol stage)
Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer
Complementary (1)
Chinese herbal medicine for oesophageal cancer
Endoscopy (1)
Percutaneous endoscopic gastrostomy versus percutaneous radiological gastrostomy for swallowing disturbances
Nutritional (3)
Percutaneous endoscopic gastrostomy versus percutaneous radiological gastrostomy for swallowing disturbances
Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Percutaneous radiological gastrostomies versus nasogastric tube feeding for people with swallowing disturbances (protocol stage)
Radiotherapy (5)
Non-surgical versus surgical treatment for oesophageal cancer
Preoperative chemoradiotherapy versus chemotherapy for adenocarcinoma of the esophagus and esophagogastric junction (AEG): systematic review with individual participant data (IPD) network meta-analysis (NMA) (protocol stage)
Preoperative radiotherapy chemotherapy and surgery versus surgery alone for esophageal cancer (protocol stage)
Preoperative radiotherapy for esophageal carcinoma
Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer
Surgery (9)
Anterior versus posterior mediastinal reconstruction after esophagectomy for patients with esophageal cancer (protocol stage)
Preoperative chemotherapy for resectable thoracic esophageal cancer
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Non-surgical versus surgical treatment for oesophageal cancer
Omentoplasty for oesophagogastrostomy after oesophagectomy
Perioperative corticosteroids for reducing postoperative complications following esophagectomy (protocol stage)
Preoperative radiotherapy chemotherapy and surgery versus surgery alone for esophageal cancer (protocol stage)
Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus
Gastro-Oesophageal Reflux Disease (GORD) (13)
Diagnosis (0)
Prevention (2)
Lifestyle (1)
Antacids and lifestyle advice for reflux oesophagitis and Endoscopy Negative Reflux Disease (protocol stage)
Pharmacology (0)
Surgery (1)
Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults
Treatment (11)
Endoscopy (0)
Lifestyle (2)
Antacids and lifestyle advice for reflux oesophagitis and Endoscopy Negative Reflux Disease (protocol stage)
Non-nutritive sucking for gastro-oesophageal reflux disease in preterm and low birth weight infants
Nutritional (0)
Pharmacology (7)
Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthrough
Cisapride treatment for gastro-oesophageal reflux in children
Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults
High dose versus standard dose proton pump inhibitor for short term management of erosive reflux oesophagitis (protocol stage)
Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults
Pharmacological treatment of children with gastro-oesophageal reflux
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease
Surgery (2)
Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults
Laparoscopic fundoplication for gastro-oesophageal reflux disease (GORD) in adults (protocol stage)
Swallowing Disorders (13)
Diagnosis (0)
Prevention (0)
Treatment (13)
Endoscopy (5)
Balloon versus bougie for dilatation of benign oesophageal strictures (protocol stage)
Percutaneous endoscopic gastrostomy versus percutaneous radiological gastrostomy for swallowing disturbances
Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia
Laparoscopic cardiomyotomy versus endoscopic pneumatic dilation for primary achalasia (protocol stage)
Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Nutritional (1)
Percutaneous radiological gastrostomies versus nasogastric tube feeding for people with swallowing disturbances (protocol stage)
Pharmacology (4)
Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders
Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia
Nitrates for achalasia
Conservative management of oesophageal soft food bolus impaction
Radiotherapy (2)
Percutaneous endoscopic gastrostomy versus percutaneous radiological gastrostomy for swallowing disturbances
Percutaneous radiological gastrostomies versus nasogastric tube feeding for people with swallowing disturbances (protocol stage)
Surgery (1)
Fundoplication in laparoscopic Heller's cardiomyotomy for achalasia
Varices (covered by the Cochrane Hepatobiliary group) (0)
Other Oesophageal Disorders (6)
Diagnosis (0)
Prevention (1)
Surgery (1)
Enhanced recovery protocols for major upper gastrointestinal, liver and pancreatic surgery
Treatment (5)
Nutritional (1)
Non-surgical interventions for eosinophilic esophagitis
Pharmacology (2)
Interventions for the management of esophageal candidiasis in immunocompromised patients (protocol stage)
Non-surgical interventions for eosinophilic esophagitis
Surgery (2)
Mesh reinforcement versus primary repair in laparoscopic paraoesophageal hernia repairs of the hiatus (protocol stage)
Preservation of the azygos vein versus ligation of the azygos vein during primary surgical repair of congenital esophageal atresia (protocol stage)
OTHER (3)
Efficacy of thalidomide in management of bleeding from gastrointestinal angiodysplasia (protocol stage)
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile) (protocol stage)
Prophylactic paracetamol for the prevention of fever in children receiving vaccination as part of a standard childhood immunization schedule (protocol stage)
STOMACH (107)
Cancer (36)
Diagnosis (1)
Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer
Endoscopy (3)
Endoscopic mucosal resection for early gastric cancer
Laparoscopic versus open resection for gastric gastrointestinal stromal tumours (GISTs) (protocol stage)
Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer
Prevention (5)
Complementary (1)
Chinese herbal medicine alone or combined with vitamins for gastric precancerous lesions (protocol stage)
Pharmacology (3)
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions
Helicobacter pylori eradication for premalignant lesions of the gastric mucosa (protocol stage)
eradication for the prevention of gastric neoplasia
Screening (1)
Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer
Treatment (24)
Chemotherapy (8)
Post-surgical chemotherapy versus surgery alone for resectable gastric cancer
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Chemotherapy for advanced gastric cancer
Molecular-targeted first-line therapy for advanced gastric cancer
Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immune checkpoint inhibitors for first- or second-line treatment of advanced gastric and gastro-esophageal junction cancer (protocol stage)
Intraperitoneal chemotherapy for gastric carcinoma (protocol stage)
Nonsteroidal anti-inflammatories (NSAIDs) and aspirin for intestinal metaplasia of the stomach (protocol stage)
Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma
Complementary (1)
Chinese herbal medicines for induction of remission in advanced or late gastric cancer
Nutritional (0)
Pharmacological (2)
Nonsteroidal anti-inflammatories (NSAIDs) and aspirin for intestinal metaplasia of the stomach (protocol stage)
Tyrosine kinase inhibitor therapies for gastrointestinal stromal tumours (protocol stage)
Radiotherapy (1)
Palliative gastric radiotherapy with or without chemotherapy versus non-radiotherapy approaches for locally advanced or metastatic (or both) gastric cancer (protocol stage)
Surgery (12)
Post-surgical chemotherapy versus surgery alone for resectable gastric cancer
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Endoscopic mucosal resection for early gastric cancer
Extent of lymph node dissection for adenocarcinoma of the stomach
Abdominal drainage versus no drainage post-gastrectomy for gastric cancer
Laparoscopic versus open gastrectomy for gastric cancer
Laparoscopic versus open resection for gastric gastrointestinal stromal tumours (GISTs) (protocol stage)
Routine cholecystectomy during Roux-en-Y gastric bypass with or without choledocholithiasis (protocol stage)
Roux-en-Y versus Billroth-I reconstruction after distal gastrectomy for gastric cancer
Stent placement versus surgical palliation for adults with malignant gastric outlet obstruction
Total gastrectomy with splenectomy versus total gastrectomy alone for gastric cancer (protocol stage)
Antecolic versus retrocolic reconstruction after partial pancreaticoduodenectomy
Palliation (3)
Chemotherapy for advanced gastric cancer
Stent placement versus surgical palliation for adults with malignant gastric outlet obstruction
Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma
Functional Dyspepsia (8)
Diagnosis (0)
Prevention (0)
Lifestyle (0)
Treatment (8)
Complementary (2)
Acupuncture for functional dyspepsia
Herbal (non-Chinese) medicines for functional dyspepsia (protocol stage)
Endoscopy (0)
Lifestyle (0)
Pharmacology (6)
Antacids, sucralfate and bismuth salts for functional dyspepsia (protocol stage)
Antidepressants and anxiolytics for functional dyspepsia (protocol stage)
Prokinetics for functional dyspepsia
Optimum antibiotic doses for Helicobacter pylori eradication (protocol stage)
Proton pump inhibitors for functional dyspepsia
Deprescribing versus continuation of chronic proton pump inhibitor use in adults
Feeding (11)
Diagnosis (3)
Carbon dioxide detection for diagnosis of inadvertent respiratory tract placement of enterogastric tubes in children (protocol stage)
Carbon dioxide detection for testing nasogastric tube placement in adults (protocol stage)
Ultrasonography for confirmation of gastric tube placement
Prevention (1)
Nutritional (1)
Post-pyloric versus gastric tube feeding for critically ill adult patients
Treatment (7)
Nutritional (6)
Electromagnetic-guided versus endoscopic-guided postpyloric placement of nasoenteral feeding tubes
Metoclopramide for post-pyloric placement of naso-enteral feeding tubes
Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Monitoring of gastric residual volume during enteral nutrition
Post-pyloric versus gastric tube feeding for critically ill adult patients
Transpyloric versus gastric tube feeding for preterm infants
Pharmacology (1)
Percutaneous endoscopic gastrostomy versus percutaneous radiological gastrostomy for swallowing disturbances
Helicobacter Pylori Infection (19)
Diagnosis (1)
Non-invasive diagnostic tests for infection
Prevention (2)
Endoscopy (1)
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding
Pharmacology (1)
eradication for the prevention of gastric neoplasia
Treatment (16)
Nutritional (1)
Probiotics as adjunctive therapy for eradication of Helicobacter pylori infection (protocol stage)
Pharmacology (15)
Eradication therapy for peptic ulcer disease in -positive people
Periodontal therapy as adjunctive treatment for gastric infection
Eradication of for iron deficiency (protocol stage)
Sequential versus standard triple first-line therapy for eradication
Helicobacter pylori eradication for premalignant lesions of the gastric mucosa (protocol stage)
Optimum duration of regimens for eradication
N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
Optimum antibiotic doses for Helicobacter pylori eradication (protocol stage)
Optimum second-line regimens for eradication (protocol stage)
Probiotics as adjunctive therapy for eradication of Helicobacter pylori infection (protocol stage)
Proton pump inhibitor- and clarithromycin-based triple therapies for Helicobacter pylori eradication (protocol stage)
Proton pump inhibitor- and fluoroquinolone-based triple therapies for eradication (protocol stage)
Deprescribing versus continuation of chronic proton pump inhibitor use in adults
Proton pump inhibitor-based triple therapies versus dual therapies for Helicobacter pylori eradication (protocol stage)
[Does eradication of the organism Helicobacter pylori from the gut of patients with Parkinson's disease improve the absorption of the main drug used to treat patients symptoms?]
Ulcer (Uncomplicated) (11)
Diagnosis (0)
Prevention (2)
Pharmacology (2)
Prevention of NSAID-induced gastroduodenal ulcers
Proton-pump inhibitors for the prevention of upper gastrointestinal bleeding in adults receiving antithrombotic therapy (protocol stage)
Treatment (9)
Nutritional (1)
Fasting for haemostasis in children with gastrointestinal bleeding
Pharmacology (8)
Eradication therapy for peptic ulcer disease in -positive people
Periodontal therapy as adjunctive treatment for gastric infection
Sequential versus standard triple first-line therapy for eradication
Optimum duration of regimens for eradication
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding
Deprescribing versus continuation of chronic proton pump inhibitor use in adults
Proton pump inhibitor-based triple therapies versus dual therapies for Helicobacter pylori eradication (protocol stage)
Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding
Ulcer (Complicated) (13)
Diagnosis (0)
Prevention (1)
Pharmacology (1)
Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units
Treatment (12)
Endoscopy (1)
Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers
Pharmacology (9)
Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers
Medical versus surgical treatment for refractory or recurrent peptic ulcer
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding
Red cell transfusion for the management of upper gastrointestinal haemorrhage
Deprescribing versus continuation of chronic proton pump inhibitor use in adults
Tranexamic acid for upper gastrointestinal bleeding
Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage
Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding
Surgery (2)
Laparoscopic repair for perforated peptic ulcer disease
Medical versus surgical treatment for refractory or recurrent peptic ulcer
Varices (covered by the Cochrane Hepatobiliary Group) (0)
Other Stomach Disorders (9)
Diagnosis (0)
Prevention (2)
Surgery (2)
Enhanced recovery protocols for major upper gastrointestinal, liver and pancreatic surgery
Routine cholecystectomy during Roux-en-Y gastric bypass with or without choledocholithiasis (protocol stage)
Treatment (7)
Nutritional (1)
The effectiveness and safety of various methods of post-pyloric feeding tube placement and verification in infants and children (protocol stage)
Palliation (1)
Stent placement versus surgical palliation for adults with malignant gastric outlet obstruction
Pharmacology (3)
Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents
Efficacy of thalidomide in management of bleeding from gastrointestinal angiodysplasia (protocol stage)
Erythromycin and related macrolides for gastroparesis (protocol stage)
Surgery (2)
Biodegradable anastomotic ring for gastrointestinal anastomosis (protocol stage)
Open versus laparoscopic pyloromyotomy for pyloric stenosis
DUODENUM (20)
Cancer (1)
Diagnosis (0)
Prevention (0)
Treatment (1)
Chemotherapy (0)
Surgery (1)
Antecolic versus retrocolic reconstruction after partial pancreaticoduodenectomy
Celiac Disease (0)
Diagnosis (0)
Prevention (0)
Treatment (0)
Functional Dyspepsia (3)
Diagnosis (0)
Prevention (0)
Lifestyle (0)
Treatment (3)
Complementary (1)
Acupuncture for functional dyspepsia
Lifestyle (0)
Pharmacology (2)
Antidepressants and anxiolytics for functional dyspepsia (protocol stage)
Prokinetics for functional dyspepsia
Ulcer (Complicated) (11)
Diagnosis (0)
Prevention (2)
Pharmacology (2)
Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units
Treatment (9)
Endoscopy (1)
Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers
Pharmacology (7)
Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding
Red cell transfusion for the management of upper gastrointestinal haemorrhage
Somatostatin or somatostatin analogues for acute non-variceal upper gastrointestinal bleeding (protocol stage)
Tranexamic acid for upper gastrointestinal bleeding
Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage
Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding
Surgery (1)
Laparoscopic repair for perforated peptic ulcer disease
Ulcer (Uncomplicated) (3)
Diagnosis (0)
Prevention (1)
Pharmacology (1)
Prevention of NSAID-induced gastroduodenal ulcers
Treatment (2)
Nutritional (1)
Fasting for haemostasis in children with gastrointestinal bleeding
Pharmacology (1)
Eradication therapy for peptic ulcer disease in -positive people
Other Duodenal Disorders (2)
Diagnosis (0)
Prevention (1)
Nutritional (0)
Surgery (1)
Enhanced recovery protocols for major upper gastrointestinal, liver and pancreatic surgery
Treatment (1)
Pharmacology (1)
Efficacy of thalidomide in management of bleeding from gastrointestinal angiodysplasia (protocol stage)
PANCREAS (95)
Cancer (34)
Diagnosis (5)
Imaging modalities for characterising focal pancreatic lesions
Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection
Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis
Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer
Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer
Treatment (29)
Chemotherapy (4)
Adjuvant chemotherapy following curative-intent resection for ampullary adenocarcinoma (protocol stage)
Erlotinib for advanced pancreatic cancer (protocol stage)
Neoadjuvant chemotherapy or chemoradiotherapy versus upfront surgery alone for resectable or borderline resectable pancreatic cancer (protocol stage)
Chemotherapy and radiotherapy for advanced pancreatic cancer
Complementary (1)
Chinese herbal medicine for advanced pancreatic cancer (protocol stage)
Endoscopy (1)
No evidence to support or refute endoscopic retrograde cholangiopancreaticography (ERCP) with stenting in patients with malignant pancreaticobiliary diseases, awaiting surgery
Nutritional (1)
Pancreatic enzyme replacement therapy for steatorrhoea in pancreatic cancer (protocol stage)
Palliation (3)
Celiac plexus block (CPB) in patients with unresectable pancreatic cancer-related pain
Palliative biliary stents for obstructing pancreatic carcinoma
Pregabalin for decreasing pancreatic pain in chronic pancreatitis
Pharmacology (2)
Pregabalin for decreasing pancreatic pain in chronic pancreatitis
Somatostatin analogues for pancreatic surgery
Radiotherapy (2)
Neoadjuvant chemotherapy or chemoradiotherapy versus upfront surgery alone for resectable or borderline resectable pancreatic cancer (protocol stage)
Chemotherapy and radiotherapy for advanced pancreatic cancer
Surgery (15)
Anastomosis to stomach versus anastomosis to jejunum for reconstructing the pancreatic stump after pancreatoduodenectomy (protocol stage)
Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy
Celiac plexus block (CPB) in patients with unresectable pancreatic cancer-related pain
Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma
Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma
Duct-to-mucosa versus other types of pancreaticojejunostomy for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy
Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Routine cholecystectomy during Roux-en-Y gastric bypass with or without choledocholithiasis (protocol stage)
Prophylactic gastrojejunostomy for unresectable periampullary carcinoma
Somatostatin analogues for pancreatic surgery
Stents for the prevention of pancreatic fistula following pancreaticoduodenectomy
Resection versus other treatments for locally advanced pancreatic cancer
Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery
Antecolic versus retrocolic reconstruction after partial pancreaticoduodenectomy
Stapler versus scalpel resection followed by hand-sewn closure of the pancreatic remnant for distal pancreatectomy
Prevention (0)
Complementary (0)
Endoscopy (0)
Lifestyle (0)
Nutritional (0)
Pharmacological (0)
Radiotherapy (0)
Screening (0)
Surgery (0)
Pancreatitis (Acute) (31)
Diagnosis (3)
Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection
Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis
Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis
Prevention (4)
Endoscopy (0)
Pharmacology (2)
Antiproteases for acute pancreatitis (protocol stage)
Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis
Radiotherapy (0)
Surgery (2)
Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis
Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis
Prognosis (1)
Prognostic models for predicting the severity and mortality in people with acute pancreatitis (protocol stage)
Treatment (23)
Complementary (1)
Chinese herbal medicines for acute pancreatitis
Endoscopy (3)
Plastic stents versus metal stents for endoscopic ultrasound-guided transmural drainage of pancreatic fluid collections (protocol stage)
Interventions for necrotising pancreatitis
Management strategies for pancreatic pseudocysts
Nutrition (6)
Fluid therapy protocols in people with acute pancreatitis (protocol stage)
Nasogastric versus nasojejunal tube feeding for severe acute pancreatitis
Nutritional supplementation in enteral and parenteral nutrition for people with acute pancreatitis (protocol stage)
Enteral versus parenteral nutrition for acute pancreatitis
Management strategies for pancreatic pseudocysts
Enteral nutrition formulations for acute pancreatitis
Pharmacology (8)
Antioxidants for acute pancreatitis (protocol stage)
Antiproteases for acute pancreatitis (protocol stage)
Lexipafant for acute pancreatitis (protocol stage)
Pharmacological interventions for acute pancreatitis
Opioids for acute pancreatitis pain
Interventions for necrotising pancreatitis
Management strategies for pancreatic pseudocysts
Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis
Surgery (5)
Continuous veno-venous hemofiltration for severe acute pancreatitis
Minimal access drainage procedures for patients with necrotising pancreatitis (protocol stage)
Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery
Interventions for necrotising pancreatitis
Management strategies for pancreatic pseudocysts
Pancreatitis (Chronic) (17)
Diagnosis (2)
Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection
Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis
Prevention (0)
Endoscopy (0)
Treatment (15)
(Maldigestion in cystic fibrosis covered by Cochrane Cystic Fibrosis Group) (0)
Endoscopy (2)
Endoscopic or surgical intervention for painful obstructive chronic pancreatitis
Management strategies for pancreatic pseudocysts
Nutritional (2)
Pancreatic enzymes for chronic pancreatitis
Management strategies for pancreatic pseudocysts
Palliation (1)
Pregabalin for decreasing pancreatic pain in chronic pancreatitis
Pharmacology (4)
Antioxidants for pain in chronic pancreatitis
Pancreatic enzymes for chronic pancreatitis
Pregabalin for decreasing pancreatic pain in chronic pancreatitis
Management strategies for pancreatic pseudocysts
Radiotherapy (1)
Management strategies for pancreatic pseudocysts
Surgery (5)
Duodenum-preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitis
Endoscopic or surgical intervention for painful obstructive chronic pancreatitis
Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery
Total pancreatectomy and islet autotransplantation for chronic pancreatitis (protocol stage)
Management strategies for pancreatic pseudocysts
Other Pancreatic Disorders (excluding Diabetes Mellitus related disorders) (13)
Diagnosis (3)
Imaging modalities for characterising focal pancreatic lesions
Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection
Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis
Prevention (2)
Surgery (2)
Prophylactic abdominal drainage for pancreatic surgery
Enhanced recovery protocols for major upper gastrointestinal, liver and pancreatic surgery
Treatment (8)
Endoscopy (1)
Management strategies for pancreatic pseudocysts
Nutritional (1)
Management strategies for pancreatic pseudocysts
Pharmacology (1)
Management strategies for pancreatic pseudocysts
Radiotherapy (1)
Management strategies for pancreatic pseudocysts
Surgery (4)
Anastomosis to stomach versus anastomosis to jejunum for reconstructing the pancreatic stump after pancreatoduodenectomy (protocol stage)
Routine cholecystectomy during Roux-en-Y gastric bypass with or without choledocholithiasis (protocol stage)
Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery
Management strategies for pancreatic pseudocysts
BOWEL (196)
Abdominal migraine (1)
Probiotics (1)
Probiotics for management of functional abdominal pain disorders in children
CROHN'S DISEASE - INDUCTION OF REMISSION (41)
Adalimumab (1)
Adalimumab for the treatment of active Crohn's disease
Adjuvant therapy with antidepressants (1)
Antidepressants for inflammatory bowel disease
Aminosalicylates (1)
Aminosalicylates for treatment of active Crohn's disease
Anti-IL-12/23 (1)
Ustekinumab and briakinumab for the treatment of active Crohn's disease
Anti-IL-17 (0)
Anti-drug antibodies (1)
Antibody development against biologic agents used for the treatment of inflammatory bowel disease and antibody prevention with immunosuppressives (protocol stage)
BCG vaccine (0)
Biosimilar infliximab (1)
Effectiveness and safety of switching IBD patients from the originator to the biosimilar infliximab (protocol stage)
Budesonide therapy (1)
Budesonide for treatment of people with active Crohn's disease.
5-aminosalicylate therapy (0)
Azathioprine or 6-mercaptopurine therapy (1)
Azathioprine or 6-mercaptopurine for the treatment of active Crohn's disease
Antibiotic therapy (1)
Antibiotics for the treatment of Crohn's disease
Cannabis (1)
Cannabis and cannabis oil for the treatment of Crohn's disease
Certolizumab pegol (1)
Certolizumab pegol for the treatment of active Crohn’s disease
Corticosteroid therapy (1)
Corticosteroids for induction of remission in Crohn's disease
Dietary interventions (1)
Diets for inducing and maintaining remission in inflammatory bowel disease (IBD)
Enteral nutritional therapy (1)
Enteral nutritional therapy for treatment of active Crohn's disease
Glutamine (1)
Glutamine for treatment of active Crohn's disease
Helminths (1)
Helminth therapy (worms) for induction of remission in inflammatory bowel disease
Herbal medicines (1)
Herbal medicines for the treatment of inflammatory bowel disease (protocol stage)
Humanized antibody to alpha4beta7 integrin (0)
Influenza vaccination (0)
Interventions for fatigue (1)
Treatments for extreme tiredness and lack of energy (fatigue) in inflammatory bowel disease
Interventions to treat strictures (0)
Low dose naltrexone (1)
Low dose naltrexone for treatment of active Crohn’s disease
Mucosal healing (0)
Mycophenolate mofetil (0)
Pain management (1)
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease
Parenteral nutritional therapy (0)
Methotrexate therapy (1)
Methotrexate for treatment of active treatment resistant Crohn's disease
Cyclosporine therapy (1)
Cyclosporine for treatment of active Crohn's disease
Placebo (0)
Prevention of hospitalization and surgery (0)
Psychological interventions (1)
Psychological interventions in inflammatory bowel disease
Quality of life (1)
The impact of biological interventions on health-related quality of life in adults with Crohn's disease (protocol stage)
Recombinant human growth hormone (somatropin) (0)
Sargramostim (GM-CSF) (1)
Sargramostim (GM-CSF) for induction of remission in Crohn's disease
Stem cell transplantation (1)
Stem cell transplantation for induction of remission in medically refractory Crohn’s disease
Surgical therapy and female fertility (1)
The risk of infertility in women with IBD who have had surgery
Tacrolimus (0)
Thalidomide (1)
Thalidomide for induction of remission in Crohn's disease
Tumor necrosis factor-alpha therapy (3)
Biologic drugs for induction and maintenance of remission in Crohn's disease: a network meta-analysis (protocol stage)
Infliximab for induction of remission in Crohn's disease (protocol stage)
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
Probiotics (1)
Probiotics for induction of remission in Crohn's disease
Recombinant human interleukin 10 (1)
Interleukin 10 (IL-10) for induction of remission in Crohn's disease
Natalizumab (1)
Natalizumab for treatment of active Crohn's disease
Validation of MRI scoring indices (1)
MRI scoring indices for evaluation of disease activity and severity in Crohn’s disease (protocol stage)
Validation of endoscopic scoring indices (1)
Endoscopic scoring indices for evaluation of disease activity in Crohn's disease
Validation of histologic scoring indices (1)
Histologic measurement tools for evaluation of disease activity in Crohn’s disease
Vedolizumab (2)
Biologic drugs for induction and maintenance of remission in Crohn's disease: a network meta-analysis (protocol stage)
Vedolizumab for induction and maintenance of remission in Crohn’s disease (protocol stage)
Vitamin D (1)
Vitamin D for the treatment of inflammatory bowel disease (protocol stage)
postoperative infectious complications (1)
Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease
CROHN'S DISEASE - MAINTENANCE OF REMISSION (41)
Adalimumab (1)
Adalimumab for maintenance of remission in Crohn's disease
Adjuvant therapy with antidepressants (1)
Antidepressants for inflammatory bowel disease
Anti-IL-12/23p40 antibodies (1)
Ustekinumab and briakinumab for the treatment of inactive Crohn's disease
Anti-drug antibodies (1)
Antibody development against biologic agents used for the treatment of inflammatory bowel disease and antibody prevention with immunosuppressives (protocol stage)
Antibiotic therapy (1)
Antibiotics for the treatment of Crohn's disease
Biosimilar infliximab (1)
Effectiveness and safety of switching IBD patients from the originator to the biosimilar infliximab (protocol stage)
Cannabis (1)
Cannabis and cannabis oil for the treatment of Crohn's disease
Certolizumab pegol (1)
Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease
Colonoscopic surveillance (1)
Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn’s disease
Corticosteroid therapy (1)
Corticosteroids for maintenance of remission in Crohn's disease
Budesonide therapy (1)
Budesonide for maintenance of remission in Crohn's disease
5-aminosalicylate therapy, topical and oral (2)
Oral 5-aminosalicylic acid drugs for maintenance of medically-induced remission in Crohn's disease
Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn’s disease
Azathioprine or 6-mercaptopurine therapy (3)
6-thioguanine nucleotide monitoring in azathioprine and mercaptopurine monotherapy for the treatment of inflammatory bowel disease (protocol stage)
Azathioprine and 6-mercaptopurine for the maintenance of surgically-induced remission in Crohn’s disease
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
Cyclosporine therapy (0)
Dietary interventions (1)
Diets for inducing and maintaining remission in inflammatory bowel disease (IBD)
Fish oil (1)
Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease
Herbal medicines (1)
Herbal medicines for the treatment of inflammatory bowel disease (protocol stage)
Infliximab (1)
Infliximab for maintenance of remission in Crohn's disease (protocol stage)
Influenza vaccination (0)
Interventions for fatigue (1)
Treatments for extreme tiredness and lack of energy (fatigue) in inflammatory bowel disease
Interventions to treat strictures (0)
Methotrexate therapy (1)
Methotrexate for treatment of inactive Crohn's disease
Anti-tuberculous therapy (1)
Anti-tuberculous therapy for maintaining remission in Crohn's disease
Enteral nutritional therapy (1)
Enteral nutrition (liquid feeds) for maintenance of remission in Crohn's disease
Mucosal healing (0)
Oral Janus kinase inhibitors (0)
Pain management (1)
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease
Placebo (0)
Post-operative recurrence (2)
Interventions for maintaining surgically included remission in Crohn's disease
Interventions for prevention of post-operative recurrence of Crohn's disease
Prevention of bone disease (0)
Prevention of hospitalization and surgery (0)
Prevention of hospitalization or surgery (0)
Psychological interventions (1)
Psychological interventions in inflammatory bowel disease
Quality of life (1)
The impact of biological interventions on health-related quality of life in adults with Crohn's disease (protocol stage)
Selective cyclooxygenase 2 inhibitors for treatment of rheumatological manifestations (1)
Tolerability of selective cyclooxygenase 2 (COX-2) inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease
Surgical therapy and female fertility (1)
The risk of infertility in women with IBD who have had surgery
Thalidomide (1)
Thalidomide for maintenance of remission in Crohn's disease
Therapy for perianal disease and fistulae (0)
Probiotics (1)
Probiotics for maintenance of remission in Crohn's disease
Recombinant human interleukin (0)
Tumor necrosis factor-alpha therapy (2)
Biologic drugs for induction and maintenance of remission in Crohn's disease: a network meta-analysis (protocol stage)
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease
Validation of MRI scoring indices (1)
MRI scoring indices for evaluation of disease activity and severity in Crohn’s disease (protocol stage)
Validation of endoscopic scoring indices (1)
Endoscopic scoring indices for evaluation of disease activity in Crohn's disease
Validation of histologic scoring indices (1)
Histologic measurement tools for evaluation of disease activity in Crohn’s disease
Vedolizumab (1)
Biologic drugs for induction and maintenance of remission in Crohn's disease: a network meta-analysis (protocol stage)
Vitamin D (1)
Vitamin D for the treatment of inflammatory bowel disease (protocol stage)
Withdrawal of drug therapy (1)
Is withdrawal of drug therapy feasible in patients with CD who have achieved remission?
Diagnostic Test Accuracy (1)
Biomarkers for assessing disease activity in inflammatory bowel disease (protocol stage)
Functional abdominal pain disorders (1)
Probiotics (1)
Probiotics for management of functional abdominal pain disorders in children
Infliximab (0)
ULCERATIVE COLITIS - INDUCTION OF REMISSION (40)
Adjuvant therapy with antidepressants (1)
Antidepressants for inflammatory bowel disease
Alicaforsen (0)
Anti-MAdCAM antibody (1)
Anti-MAdCAM antibody for induction of remission in ulcerative colitis (protocol stage)
Anti-drug antibodies (1)
Antibody development against biologic agents used for the treatment of inflammatory bowel disease and antibody prevention with immunosuppressives (protocol stage)
Antibiotics (1)
Antibiotics for the induction and maintenance of remission in ulcerative colitis
Biosimilar infliximab (1)
Effectiveness and safety of switching IBD patients from the originator to the biosimilar infliximab (protocol stage)
Cannabis (1)
Cannabis and cannabis oil for the treatment of ulcerative colitis
Dietary interventions (1)
Diets for inducing and maintaining remission in inflammatory bowel disease (IBD)
Etrolizumab (1)
Etrolizumab for the treatment of active ulcerative colitis
Fecal transplantation (1)
Stool transplantation for treatment of inflammatory bowel disease
Fish oil (1)
Fish oil for the treatment of active ulcerative colitis
Helminths (1)
Helminth therapy (worms) for induction of remission in inflammatory bowel disease
Heparin (1)
Unfractionated or low molecular weight heparin for treatment of active ulcerative colitis
Herbal medicines (1)
Herbal medicines for the treatment of inflammatory bowel disease (protocol stage)
Humanized antibody to alpha4beta7 integrin (1)
Vedolizumab for the treatment of active and inactive ulcerative colitis
Influenza vaccination (0)
Interferons (1)
Type I interferons for treatment of active ulcerative colitis
Interventions for fatigue (1)
Treatments for extreme tiredness and lack of energy (fatigue) in inflammatory bowel disease
Methotrexate (1)
Methotrexate for treatment of chronic active ulcerative colitis
Mucosal healing (0)
Oral janus kinase inhibitors (1)
Oral janus kinase inhibitors for induction of remission in ulcerative colitis (protocol stage)
Pain management (1)
Interventions for the management of abdominal pain in ulcerative colitis
Placebo (1)
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis
Prebiotics (1)
Prebiotics for induction of remission in ulcerative colitis (protocol stage)
Psychological interventions (1)
Psychological interventions in inflammatory bowel disease
Quality of life (1)
The impact of biological interventions for ulcerative colitis on health-related quality of life
Short chain fatty acids (0)
Surgical therapy and female fertility (1)
The risk of infertility in women with IBD who have had surgery
Tacrolimus (1)
Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis
Topical corticosteroid therapy (1)
Rectal corticosteroids for induction of remission in ulcerative colitis (protocol stage)
Oral corticosteroid therapy (1)
Oral corticosteroids for induction of remission in ulcerative colitis (protocol stage)
Budesonide therapy (1)
Oral budesonide for treatment of people with active ulcerative colitis
5-ASA therapy, topical and oral (2)
5-ASA suppositories, enemas or foam for induction of remission in ulcerative colitis
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
Cyclosporine therapy (1)
Cyclosporine A for induction of remission in severe ulcerative colitis
Active pouchitis (1)
Therapy for treatment and prevention of pouchitis
Parenteral nutritional therapy (0)
Traditional Chinese medicinal herbs (0)
Tumor necrosis factor-alpha therapy (1)
Tumour necrosis factor alpha blocking agents for treatment of active ulcerative colitis
Probiotics (1)
Probiotics for the treatment of active ulcerative colitis
Transdermal nicotine (1)
Transdermal nicotine for the treatment of active ulcerative colitis
Azathioprine (0)
Validation of endoscopic scoring indices (1)
Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis
Validation of histologic scoring indices (1)
Histologic measurement tools for evaluating disease in ulcerative colitis patients
Vedolizumab (1)
Vedolizumab for the treatment of active and inactive ulcerative colitis
Vitamin D (1)
Vitamin D for the treatment of inflammatory bowel disease (protocol stage)
postoperative infectious complications (1)
Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease
ULCERATIVE COLITIS - MAINTENANCE OF REMISSION (30)
Adjuvant therapy with antidepressants (1)
Antidepressants for inflammatory bowel disease
Anti-drug antibodies (1)
Antibody development against biologic agents used for the treatment of inflammatory bowel disease and antibody prevention with immunosuppressives (protocol stage)
Antibiotics (1)
Antibiotics for the induction and maintenance of remission in ulcerative colitis
Biosimilar infliximab (1)
Effectiveness and safety of switching IBD patients from the originator to the biosimilar infliximab (protocol stage)
Cannabis (1)
Cannabis and cannabis oil for the treatment of ulcerative colitis
Corticosteroid therapy (1)
Rectal corticosteroids for maintenance of remission in ulcerative colitis (protocol stage)
5-aminosalicylate therapy (2)
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
Rectal 5-aminosalicylic acid (suppository, foam or liquid enema) for maintenance of remission in ulcerative colitis
Azathioprine and 6-mercaptopurine therapy (2)
6-thioguanine nucleotide monitoring in azathioprine and mercaptopurine monotherapy for the treatment of inflammatory bowel disease (protocol stage)
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis
Cancer surveillance in IBD (1)
Strategies for detecting colon cancer in patients with inflammatory bowel disease
Curcumin (1)
Curcumin for maintenance of remission in ulcerative colitis
Dietary interventions (1)
Diets for inducing and maintaining remission in inflammatory bowel disease (IBD)
Fecal transplantation (1)
Stool transplantation for treatment of inflammatory bowel disease
Fish oil (1)
Omega 3 fatty acids for maintenance of remission in ulcerative colitis
Herbal medicines (1)
Herbal medicines for the treatment of inflammatory bowel disease (protocol stage)
Influenza vaccination (0)
Interventions for fatigue (1)
Treatments for extreme tiredness and lack of energy (fatigue) in inflammatory bowel disease
Methotrexate (1)
Methotrexate for keeping ulcerative colitis inactive   
Mucosal healing (0)
Oral Janus kinase inhibitors (1)
Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis
Pain management (1)
Interventions for the management of abdominal pain in ulcerative colitis
Placebo (1)
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis
Prevention of bone disease (0)
Probiotics (1)
Probiotics for maintenance of remission in ulcerative colitis
Psychological interventions (1)
Psychological interventions in inflammatory bowel disease
Quality of life (1)
The impact of biological interventions for ulcerative colitis on health-related quality of life
Selective cyclooxygenase 2 inhibitors for treatment of rheumatological manifestations (1)
Tolerability of selective cyclooxygenase 2 (COX-2) inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease
Surgical therapy and female fertility (1)
The risk of infertility in women with IBD who have had surgery
Transdermal nicotine (0)
Tumor necrosis alpha therapy (0)
Validation of endoscopic scoring indices (1)
Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis
Validation of histologic scoring indices (1)
Histologic measurement tools for evaluating disease in ulcerative colitis patients
Vedolizumab (1)
Vedolizumab for the treatment of active and inactive ulcerative colitis
Vitamin D (1)
Vitamin D for the treatment of inflammatory bowel disease (protocol stage)
Irritable Bowel Syndrome (14)
5-aminosalicylate therapy (1)
5-aminosalicylic acid analogues for treatment of irritable bowel syndrome (protocol stage)
Antibiotics (1)
Antibiotics for treatment of irritable bowel syndrome in adults (protocol stage)
Antidepressants (1)
Antidepressants for functional abdominal pain disorders in children and adolescents
Biofeedback (1)
Biofeedback for the treatment of irritable bowel syndrome
Bulking agents, antispasmodics and antidepressant medication (1)
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Calcium channel blockers (0)
Herbal medicines (1)
Herbal medicines for treatment of irritable bowel syndrome
Homeopathy (1)
Homeopathy for treatment of irritable bowel syndrome
Loperamide (0)
Low FODMAP diet (0)
Physical activity (1)
Physical activity for treatment of irritable bowel syndrome
Psychological treatments (1)
Psychological treatments for the management of irritable bowel syndrome
Tegaserod (1)
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation
Prokinetic drugs (0)
Acupuncture (1)
Acupuncture for irritable bowel syndrome
Hypnotherapy (1)
Hypnotherapy (treatment by hypnosis) for the treatment of irritable bowel syndrome
Probiotic agents (2)
Probiotics for management of functional abdominal pain disorders in children
Probiotics for the treatment of irritable bowel syndrome in children (protocol stage)
Chronic constipation (9)
Abdominal massage (1)
Abdominal massage for the treatment of constipation (protocol stage)
Acupuncture (1)
Acupuncture for chronic constipation (protocol stage)
Antibiotics (0)
Antidepressants (1)
Antidepressants for functional abdominal pain disorders in children and adolescents
Biofeedback therapy (1)
Biofeedback (use of equipment to retrain the muscles around the anus and coordinated pushing) for the treatment of chronic constipation in adults
Botulinum toxin (0)
Fiber and bulking agents (1)
Fiber and bulking agents for the treatment of chronic constipation (protocol stage)
Herbal medicines (0)
Linaclotide (0)
Management of constipation in the elderly and chronically ill (0)
Polyethylene glycol (0)
Probiotics (1)
Probiotics for treatment of chronic constipation in children
Prucalopride (1)
Prucalopride for the treatment of chronic constipation (protocol stage)
Reflexology (1)
Reflexology for treatment of constipation (protocol stage)
Tegaserod (1)
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation
OTHER (18)
Childhood constipation and soiling (4)
Laxatives for the management of childhood constipation
Stimulant laxatives for constipation and soiling in children
Transcutaneous electrical stimulation (TES) for treating long-term constipation in children.
Treatments for intractable constipation in childhood (protocol stage)
Collagenous colitis (1)
Treatments for collagenous colitis
Enterocutaneous fistula (0)
Growth failure in Crohn's disease (1)
Interventions for growth failure in childhood Crohn's disease
Hirschsprung-associated enterocolitis (1)
Probiotics for the prevention of Hirschsprung-associated enterocolitis
Inflammatory bowel disease (3)
Patient education interventions for the management of Inflammatory Bowel Disease (protocol stage)
Remote care through telehealth for people with inflammatory bowel disease (protocol stage)
Interventions for treating iron deficiency anaemia in inflammatory bowel disease
Radiation colitis, enteritis and proctitis (0)
Clostridium difficile-associated diarrhea (2)
Antibiotic therapy for Clostridium difficile-associated diarrhoea in adults
The use of probiotics to prevent Clostridium difficile diarrhea associated with antibiotic use
Clostridium difficile-associated colitis (1)
Probiotics for treatment of Clostridium difficile -associated colitis in adults
Antibiotic-associated diarrhea (1)
Probiotics for the prevention of antibiotic-associated diarrhea in children
Lymphocytic colitis (1)
Treatments for lymphocytic colitis
Short bowel syndrome (2)
Human growth hormone and glutamine for patients with short bowel syndrome
Teduglutide for the treatment of patients with short bowel syndrome (protocol stage)
Specialist nursing interventions (1)
Specialist nurse counselling interventions for patients with inflammatory bowel disease
Symptomatic uncomplicated diverticular disease (SUDD) (0)